09960 康聖環球
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
29/01/2026Mialkos Tomasz Jakub1101(L)+385,000(L)HKD 1.212(L)83,308,500(L)8.00
19/11/2025Mialkos Tomasz Jakub1101(L)+524,000(L)HKD 1.272(L)72,912,000(L)7.00
06/10/2025Mialkos Tomasz Jakub1101(L)+262,500(L)HKD 1.532(L)62,480,500(L)6.00
27/06/2025OrbiMed Asia GP IV, L.P.1101(L)+10,000,000(L)70,444,835(L)6.77
27/06/2025OrbiMed Advisors IV Limited1101(L)+10,000,000(L)70,444,835(L)6.77
27/06/2025OrbiMed Asia Partners IV, L.P.1101(L)+10,000,000(L)70,444,835(L)6.77
14/05/2025Mialkos Tomasz Jakub1001(L)+177,000(L)HKD 1.340(L)52,177,500(L)5.01
25/03/2025OrbiMed Advisors IV Limited1001(L)+2,758,500(L)HKD 1.400(L)52,410,335(L)5.04
25/03/2025OrbiMed Asia GP IV, L.P.1001(L)+2,758,500(L)HKD 1.400(L)52,410,335(L)5.04
25/03/2025OrbiMed Asia Partners IV, L.P.1001(L)+2,758,500(L)HKD 1.400(L)52,410,335(L)5.04
24/01/2025涂贊兵1711(L)64,361,864(L)6.18
24/01/2025黄博1213(L)99,299,404(L)9.54
24/01/2025黃瑞瑨1711(L)73,119,632(L)7.02
24/01/2025CPE Holdings International Limited1213(L)80,367,640(L)7.72
24/01/2025Jackson Hole Trust Company1213(L)99,299,404(L)9.54
24/01/2025Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.1213(L)72,539,632(L)6.97
24/01/2025黃士昂1711(L)146,425,868(L)14.07
24/01/2025柴海節1711(L)10,166,456(L)0.97
24/01/2025CPE Funds III Limited1213(L)80,367,640(L)7.72
24/01/2025CPE Holdings Limited1213(L)80,367,640(L)7.72
24/01/2025CK Lab Tech Investment Limited1213(L)80,367,640(L)7.72
24/01/2025CPEChina Fund III, L.P.1213(L)80,367,640(L)7.72
 1  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.